ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Billings, C.
Right arrow Articles by Howard, P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Billings, C.
Right arrow Articles by Howard, P
Eur Respir J 1994; 7: 1172-1176
Copyright © ERS Journals Ltd 1994


Original Articles

Hypothesis: exposure to solvents may cause fibrosing alveolitis

CG Billings and P Howard

The incidence of fibrosing alveolitis, which can be caused by many agents, is increasing. In a proportion of patients, the aetiology is unknown (cryptogenic fibrosing alveolitis), but it has been suggested that environmental factors may play an important, but unrecognized, role in its pathogenesis. A review of the literature suggests that there may be a link between exposure to solvents, widespread occupational pollutants, and fibrosing alveolitis. Experimental work in animals has shown that exposure to solvents produces changes in the lung similar to those found in fibrosing alveolitis. Occupational exposure to a wide number of solvents has been associated with the development of systemic sclerosis. Pulmonary involvement in systemic sclerosis is morphologically indistinguishable from fibrosing alveolitis, and a close relationship between the two diseases seems to exist. This close relationship and the experimental work linking solvent exposure to fibrosing alveolitis suggest that solvent exposure may be one cause of cryptogenic fibrosing alveolitis. Determination of any occupational exposure of patients with cryptogenic fibrosing alveolitis may help in the understanding and prevention of this disease.


This article has been cited by other articles:


Home page
ChestHome page
T. Enomoto, J. Usuki, A. Azuma, T. Nakagawa, and S. Kudoh
Diabetes Mellitus May Increase Risk for Idiopathic Pulmonary Fibrosis
Chest, June 1, 2003; 123(6): 2007 - 2011.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
B. G. Kelly, S. S. Lok, P. S. Hasleton, J. J. Egan, and J. P. Stewart
A Rearranged Form of Epstein-Barr Virus DNA Is Associated with Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med., August 15, 2002; 166(4): 510 - 513.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
M. Selman, T. E. King Jr., and A. Pardo
Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy
Ann Intern Med, January 16, 2001; 134(2): 136 - 151.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
S. C Bourke and H. Clague
Review of cryptogenic fibrosing alveolitis, including current treatment guidelines
Postgrad. Med. J., October 1, 2000; 76(900): 618 - 624.
[Full Text]


Home page
Toxicol PatholHome page
R. F. Robledo, R. S. Young, R. C. Lantz, and M. L. Witten
Short-Term Pulmonary Response to Inhaled JP-8 Jet Fuel Aerosol in Mice
Toxicol Pathol, September 1, 2000; 28(5): 656 - 663.
[Abstract] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
T. King
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment . International Consensus Statement
Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): 646 - 664.
[Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. P. STEWART, J. J. EGAN, A. J. ROSS, B. G. KELLY, S. S. LOK, P. S. HASLETON, and A. A. WOODCOCK
The Detection of Epstein-Barr Virus DNA in Lung Tissue from Patients with Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med., April 1, 1999; 159(4): 1336 - 1341.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the European Respiratory Society.